Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.
Leidos Holdings, Inc. (NYSE: LDOS) is a leading science and technology company that provides services and solutions in defense, intelligence, civil, and health markets. Headquartered in Reston, Virginia, Leidos leverages the expertise of its 47,000 employees to tackle some of the world's most pressing challenges. The company is divided into several segments, each catering to specific industries:
- National Security and Digital: Focuses on cyber, logistics, security operations, and digital transformation for defense and intelligence customers.
- Health & Civil: Delivers public health solutions, care coordination, and environmental sciences services.
- Commercial & International: Covers security enterprise solutions, commercial energy offerings, and international business.
- Defense Systems: Develops advanced space, aerial, surface, and subsurface defense systems.
Leidos reported revenues of approximately $15.4 billion for the fiscal year ending December 29, 2023. The company’s recent projects include:
- Development of C2IMERA: An advanced command and control tool for the U.S. Air Force.
- MHS GENESIS Deployment: A federal electronic health record system implemented across all Department of Defense garrison facilities.
- Mayhem Hypersonic System: Advancing air-breathing hypersonic technologies through a collaborative national team effort.
Financially, Leidos had a strong 2023 with revenues up by 7%, achieving a record net income margin of 7.1% in the first quarter of 2024. The company remains committed to innovation, operational efficiency, and addressing emerging threats in national security and health.
Leidos (NYSE:LDOS) announces leadership changes effective July 5, aimed at optimizing internal processes and talent development. Paul Engola is appointed EVP, National Security Space, while George Reiter becomes acting CHRO. Jim Cantor will retire, leading to the creation of a Corporate Operations role, with Vicki Schmanske stepping in as EVP. Roy Stevens will replace Vicki as president of the Intelligence Group. CEO Roger Krone emphasizes the importance of flexibility to address customer needs in evolving markets. Leidos reported annual revenues of $12.30 billion for FY 2021.
Leidos (NYSE:LDOS) has secured a $2.5 billion contract from NASA for the Advanced Enterprise Global Information Technology Solutions (AEGIS) project. This contract spans 10 years if all options are exercised and aims to enhance NASA's telecommunications, cloud, and data center services across all facilities. Leidos will provide critical support for NASA’s IT infrastructure, ensuring mission-critical operations, including cybersecurity and emergency systems. This award follows Leidos' ongoing collaboration with NASA through its NEST contract, supporting the agency's overall IT operations.
Leidos (NYSE: LDOS) has scheduled its second quarter 2021 earnings conference call for August 3, 2021, at 8 a.m. ET. The call will follow an earnings press release issued earlier that day. Interested parties can listen via telephone or through a live stream on the company's Investor Relations website. A replay will be accessible from August 3 at 11:30 a.m. ET until August 10 at 11:59 p.m. ET. Leidos reported approximately $12.30 billion in annual revenues for the fiscal year ending January 1, 2021.
Leidos (NYSE: LDOS) has been awarded a prime contract valued at $950 million by the U.S. Air Force to deliver solutions for aviation requirements over a 13-year period. This indefinite delivery/indefinite quantity contract includes a 10-year ordering period and an additional 3-year performance period. Leidos will enhance ISR capabilities and support the Air Force's efforts in ensuring multi-domain dominance. The work will be conducted globally, benefiting U.S. and allied forces.
Leidos (NYSE: LDOS) has secured a prime contract with the Transportation Security Authority (TSA) valued at $470.7 million to assist in deploying Transportation Screening Equipment (TSE) across U.S. federalized airports. This indefinite delivery/indefinite quantity contract will enable Leidos to conduct surveys, provide design support, and oversee the installation, relocation, and removal of screening equipment. Leidos has previously supported TSA for over 12 years, enhancing operational efficiency and safety at airports and special events.
Leidos has been awarded a prime contract by the CDC to provide bioinformatics and scientific computing support services, valued at over $13 million over five years. This contract enhances CDC's capacity in handling large datasets and high-performance computing for health-related research. The work will be primarily based in Atlanta, Georgia.
Liz Porter, Leidos Health Group president, emphasized the importance of this collaboration in investigating infectious pathogens and advancing public health.
Leidos Holdings has extended its offers for the exchange of various notes totaling $2.25 billion, including 2.950% Notes due 2023 and others, to expire on June 21, 2021. This extension is due to the announcement that June 18 will be a federal holiday. As of June 17, 2021, the company reported significant tendering amounts: 59.7% for the 2023 Notes and over 85% for the 2025 Notes. Other notes tendered include 70.1% for the 2030 Notes and 81.1% for the 2031 Notes. Citibank is the exchange agent for the offers.
Leidos (NYSE: LDOS) has secured a prime contract from the U.S. Army for commercial health services to military reserve forces, valued at $999 million if all options are exercised. This contract spans a one-year base period, with four additional one-year options. Leidos will collaborate with the Defense Health Agency to meet health requirements for service members before, during, and after deployment. Liz Porter, the Health Group president, emphasized the commitment to serving military reservists, while CEO Larry Schaefer stressed the dedication to innovation and customer service in healthcare.
Leidos (NYSE: LDOS) announced its advancement into the final phase of the USSOCOM's Armed Overwatch aircraft prototype program alongside Paramount USA and Vertex. The team has been awarded $19.3 million for prototype demonstrations, focusing on the Bronco II aircraft, which boasts mission flexibility through its Interchangeable Multi-Mission System Bay. Leidos' team aims to showcase the Bronco II's capabilities for ISR, SCAR, and CAS missions. The program is critical for future military operational requirements, showcasing Leidos' ongoing commitment to innovative defense solutions.
Leidos (NYSE: LDOS) announced its advancement to Phase III of the U.S. Special Operations Command's Armed Overwatch aircraft prototype program with its Bronco II aircraft. Partnering with Paramount Group USA and Vertex Aerospace, the Leidos team will demonstrate the aircraft's capabilities in a fly-off. Bronco II is designed for rapid deployment and modularity, allowing for diverse mission configurations. This contract signifies Leidos' commitment to providing advanced military solutions and supporting national defense.